Literature DB >> 8866636

Lack of effect of zinc supplementation on antipyrine clearance in alcoholic liver disease.

K Grønbaek1, H Friis, M Feldman, J Sonne, P B Andreasen.   

Abstract

METHODS: The effect of zinc supplementation on antipyrine clearance was evaluated in 14 outpatients with stable alcoholic liver disease, of whom nine had biopsy proven alcoholic cirrhosis.
RESULTS: There was no change in antipyrine clearance after 14 days of zinc supplementation (median 12.5 vs 12.9 ml.min-1). However, a significant increase in P-prothrombin-proconvertin was found. There was a positive correlation between S-zinc and antipyrine clearance at inclusion (rs = 0.76) as well as after zinc supplementation (rs = 0.72).
CONCLUSION: No effect of zinc supplementation on antipyrine clearance was found. The positive correlation between S-zinc and antipyrine clearance could be due to the confounding effect of alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866636     DOI: 10.1007/bf00203785

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Zinc metabolism in hepatic dysfunction. II. Correlation of metabolic patterns with biochemical findings.

Authors:  B L VALLEE; W E WACKER; A F BARTHOLOMAY; F L HOCH
Journal:  N Engl J Med       Date:  1957-11-28       Impact factor: 91.245

Review 2.  Assessment of zinc status.

Authors:  J C King
Journal:  J Nutr       Date:  1990-11       Impact factor: 4.798

3.  Serum zinc and serum copper and indices of drug metabolism in alcoholics.

Authors:  T R Hartoma; E A Sotaniemi; O Pelkonen; J Ahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

Review 4.  Antipyrine as a model drug to study hepatic drug-metabolizing capacity.

Authors:  H E Poulsen; S Loft
Journal:  J Hepatol       Date:  1988-06       Impact factor: 25.083

5.  Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.

Authors:  P B Andreasen; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

Review 6.  The biochemical basis of zinc physiology.

Authors:  B L Vallee; K H Falchuk
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

7.  Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis.

Authors:  L S Valberg; P R Flanagan; C N Ghent; M J Chamberlain
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

8.  Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial.

Authors:  K Weismann; E Christensen; V Dreyer
Journal:  Acta Med Scand       Date:  1979

9.  Zinc depletion in alcoholic liver diseases.

Authors:  S Kiilerich; O Dietrichson; F B Loud; J Naestoft; P Christoffersen; E Juhl; G Kjems; C Christiansen
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

10.  Alterations in zinc, vitamin A, and retinol-binding protein in chronic alcoholics: a possible mechanism for night blindness and hypogonadism.

Authors:  C J McClain; D H Van Thiel; S Parker; L K Badzin; H Gilbert
Journal:  Alcohol Clin Exp Res       Date:  1979-04       Impact factor: 3.455

View more
  1 in total

Review 1.  Zinc and the liver: an active interaction.

Authors:  Ioannis Stamoulis; Grigorios Kouraklis; Stamatios Theocharis
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.487

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.